Molnupiravir improves outcomes in non-hospitalized COVID-19 patients
1. In coronavirus disease 2019 (COVID-19) patients, molnupiravir was associated with earlier and...
Read MoreJun 25, 2022
1. In coronavirus disease 2019 (COVID-19) patients, molnupiravir was associated with earlier and...
Read MoreJun 25, 2022
1. In this phase 2a study, the RSVpreF vaccine was effective against symptomatic respiratory...
Read MoreJun 25, 2022
1. Vitamin and mineral supplementation was associated with minimal to no benefit in preventing...
Read MoreJun 21, 2022
1. In patients with mild-to-moderate coronavirus disease 2019 (COVID-19), sotrovimab reduced the...
Read MoreJun 21, 2022
1. Among a large cohort of US veterans, the 38-week risks of adverse events were low in both...
Read MoreJun 21, 2022
1. The Moderna mRNA vaccine significantly decreased the risk of contracting coronavirus disease...
Read MoreJun 21, 2022
1. In a large cohort of children screened for risk factors such as food insecurity and housing...
Read MoreJun 4, 2022
1. In this clustered, randomized controlled trial, children who were limited to 3 hours of screen...
Read MoreJun 2, 2022
1. Among a group of risky drinkers seeking online help in Sweden, a digital alcohol intervention...
Read MoreJun 2, 2022
1. This cohort study found that among 623,140 individuals participating in the Asia Cohort...
Read MoreJun 2, 2022
1. This retrospective cohort study using the TARGet Kids! Cohort demonstrated that late and...
Read MoreMay 25, 2022
1. This cross-sectional study demonstrated no significant increase in major surgical complications...
Read MoreMay 24, 2022
Monitoring patients with coexistent AF and obesity by setting weekly goals and sending text...
Read MoreMay 20, 2022
1. In a large cohort study, children presenting to emergency departments with a score of 2 or...
Read MoreMay 19, 2022
1. Cabotegravir was shown to be superior to TDF-FTC in preventing HIV infection in women. 2. Both...
Read MoreMay 14, 2022
1. Patients receiving the fourth dose of BNT162b2 (Pfizer-BioNTech) showed reduced rates of...
Read MoreMay 14, 2022
1. Dapagliflozin reduced the risk of worsening heart failure or cardiovascular death regardless of...
Read MoreMay 14, 2022
1. Adding a mask recommendation to other public measures did not reduce the SARS-Cov-2 infection...
Read MoreMay 14, 2022
1. A two-dose regimen of BNT162b2 at 10μg elicits a sufficient immune response in children 5 – 11...
Read MoreMay 14, 2022
1. One dose of Ad26.COV2.S (Johnson & Johnson) provided some protection against moderate to...
Read More